Purpose
Preclinical studies have demonstrated that intraprostatic/ intratumoral (IT) administration of vaccine in combination with systemic vaccination (SC) may improve antitumor efficacy. In this study we assessed the differential effects of IT/SC vaccination in peripheral blood mononuclear cells (PBMCs) and tumor-infiltrating lymphocytes (TILs).
Methods
Measurements were performed before and near day 113 post IT/SC administration of PSA-TRICOM vaccine in 21 patients (pts) with locally recurrent or progressive prostate cancer (PC) enrolled in a dose-escalation phase 1 trial. Pts received initial SC vaccination with recombinant vaccinia-PSA-TRICOM and IT boosts with recombinant fowlpox (rF)-PSA-TRICOM. Cohort 3-5 received intraprostatic rF-GM-CSF. Cohort 5 received SC boosts with rF-PSA-TRICOM and rF-GM-CSF. We evaluated Treg suppression, NK function, and frequencies of immune cell subsets from PBMC by flow-cytometry. TILs were measured by digital immunohistochemistry (IHC). Prostate cores were obtained by transrectal ultrasound-guided biopsies. Prostate sections were stained for CD4, CD8, FoxP3, or isotype controls. Digital IHC images were acquired with an Aperio ScanScope AT Turbo and analyzed with the Aperio ImageScope membrane algorithm for cell membrane analysis. CD4 + TILs positive for FoxP3 (putative Tregs) were counted manually.
Results
The 
Conclusions
The use of digital IHC after IT/SC vaccination can help to document variations of immune infiltration and clinical correlates in the absence of relevant changes in PBMC immune cell subsets.
